Japanese Government Hepatitis C Compensation Clears Final Diet Hurdle
This article was originally published in PharmAsia News
Japan's Diet legislative body voted final approval of a bill that offers compensation to some of the more than 1,000 people who sued over hepatitis C infections caused by tainted blood. The government and drug makers were targets of the suits by patients, or their families in the cases of those who died as a result of receiving the blood products. The government action accepts responsibility for failing to take action to prevent the harm from spreading to others. The House of Councilors vote adding its approval of the measure passed earlier by the House was expected to clear the way for out-of-court settlements of most of the suits. (Click here for more
You may also be interested in...
The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.